The market has morphed since the advent of CVs. The largest marquee assets may need to rely on the IPO market for exits. However, in the mid-market space (or $10 million-$100 million of EBITDA businesses), companies continue to have various exit options available, namely sales to strategics, sales to other sponsors, or IPOs if they become large enough.